Produit
AGENTS IA
APPLICATIONS DE L'IA
AUTRES
Solutions
SECTEURS D'ACTIVITÉ
USE CASES
Tarification
Ressources
EXPLORER
ENGAGER
ASSISTANCE ET SERVICES
À propos
Plateforme PatSnap Eureka
Mandataires en propriété intellectuelle
Agents pour l'ingénierie
Agents pour les sciences de la vie
Agents pour matériaux
PatSnap Eureka Desktop
NEWAnalytique
Intelligence IPSynapse
Renseignement biopharmaceutiqueBiographie
Recherche et analyse de séquences biologiquesChimique
Recherche et analyse de structures chimiquesPlateforme ouverte
NEWServices professionnels
Cabinets d'avocats
Sciences de la vie
Haute technologie
Competitor Tech Research
Design Risk Screening
Cosmetic Formulation
Telecom SEP Claim Chart
Accès à plus de 2 000 000 000 points de données structurées dans les domaines des brevets, des sciences, des litiges et des technologies.
Innovez 75 % plus vite à un coût réduit de 25 %.
Cloud ou sur site pour une confidentialité et un contrôle maximaux
Reconnu par plus de 18 000 innovateurs à travers le monde
Pour l'utiliser, cliquez sur le bouton de vérification dans l'e-mail que nous avons envoyé à [email protected].
Cela contribue à sécuriser votre compte.
Vous devriez le recevoir sous peu. N'oubliez pas de vérifier votre dossier spam.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Série soigneusement sélectionnée offrant des informations précieuses aux professionnels de l'innovation.
Article | Rapport MCL-1 overexpression drives venetoclax resistance in AML, DLBCL, and myeloma. Explore direct inhibitors, CDK9 suppression, NOXA induction, and combination strategies.
Article | Rapport Mapping the 2026 quantum dot solar concentrator patent and literature landscape: LSC efficiencies, QDSSC records, geographic IP hotspots, and emerging eco-design strategies.
Article | Rapport How to improve oxidation stability of sulfide solid electrolytes at the cathode interface without sacrificing ionic conductivity — strategies from 20+ patents and studies.
Article | Rapport Explore the 2026 electrochemical methane activation landscape: key catalyst clusters, SOEC selectivity data, ambient-condition breakthroughs, and strategic IP implications.
Article | Rapport How aryl-sulfonamide molecular glues degrade RBM39 via CRL4-DCAF15, driving activity in leukemia, neuroblastoma, and ovarian cancer. Pipeline and IP signals.
Article | Rapport How single-ion conducting polymer electrolytes push lithium transference numbers toward unity, eliminate concentration polarization, and suppress dendrite growth in lithium metal batteries.
Article | Rapport A deep-dive into thermoelectric module packaging innovation: hermetic encapsulation, flexible substrates, IC spot-cooling, and the assignees shaping the 2026 landscape.
Article | Rapport How cryo-EM reveals atomic-scale SEI nanostructure in lithium-metal, lithium-ion, and sodium batteries — key findings, workflows, and research trends.
Article | Rapport How NPC and NSC therapies are advancing stroke recovery, spinal cord injury, and neurodegeneration — from iPSC-derived cells to Phase II trials.
Article | Rapport Explore the 2026 thermoelectric module packaging landscape: hermetic encapsulation, flexible substrates, IC spot-cooling, and key patent assignees from Kyocera to Google.
Article | Rapport How cryo-EM reveals atomic-scale SEI nanostructure in next-generation batteries — key findings on Li₂CO₃ stability, 3D conformality, and sodium systems.
Article | Rapport How LNP-delivered mRNA and engineered viral vectors are reshaping CAR-T therapy by programming T cells directly inside the body — bypassing costly ex vivo manufacturing.
Article | Rapport Microrobotic drug delivery is approaching clinical translation. Explore propulsion mechanisms, application domains, geographic leaders, and emerging IP opportunities in this 2026 landscape.
Article | Rapport How do hot carrier injection and bias temperature instability differ as dominant aging mechanisms at 3nm? Physics, scaling behavior, and coupled interactions explained.
Article | Rapport Explore the dendritic cell vaccine therapy pipeline in solid tumors: personalized antigen loading, mRNA electroporation, DC-tumor fusion, and checkpoint combination strategies.